Breaking News Instant updates and real-time market news.

CNTY

Century Casinos

$4.10 /

+0.16 (+4.06%)

06:07
05/20/20
05/20
06:07
05/20/20
06:07

Century Casinos provides business update amid COVID-19 pandemic

The company said, "In late 2019, an outbreak of COVID-19 was identified in China and has since spread throughout much of the world. The COVID-19 pandemic has had an adverse effect on the Company's first quarter 2020 results of operations and financial condition, and we expect this situation will have an adverse impact on our second quarter 2020 results. The trends below are not the only items that could impact the Company's future performance, and the views of management are preliminary based on currently available information. Between March 14, 2020 and March 17, 2020, the Company closed all of its casinos, hotels and other facilities to comply with quarantines issued by governments to contain the spread of COVID-19. The Company anticipates a phased approach to reopening will be recommended by government officials in the jurisdictions where it operates, which could include reduced levels of gaming space, social distancing at slot machines and table games or reduced capacity within the casino, limited restaurant operating hours or continued closure of restaurants, requirements to wear face masks, including the potential to require guests to wear face masks, increased frequency of disinfecting surfaces and other measures to account for varying levels of demand. The Company's casinos rely on a local customer base and, as such, the Company anticipates that its operations could resume at a quicker rate than those of casinos at destination resorts. The timing for reopening the Company's closed locations will depend on determinations by governments in each jurisdiction. The Company reopened its Poland casinos on May 18, 2020. Based on information currently available, the Company is anticipating reopening most of its other locations beginning in June 2020 and no later than August 2020. However, the Company cannot predict how quickly customers will return to its casinos. The Company permanently closed Century Casino Bath in March 2020 and four of the ship-based casinos that the Company operated prior to their closures in March 2020 will not reopen due to expiration of the Company's concession agreements for those casinos. Due to the temporary closures of its casinos, hotels and other facilities, the Company has taken actions to reduce operating costs, including furloughing most of its personnel and implementing reduced work weeks for other personnel. During the closures, the Company will continue to pay benefits to its United States and Canadian employees, inclusive of part time employees, through May 2020. In Poland, all employees were paid reduced salaries based on local employment laws. In March 2020, as a proactive measure to increase its cash position and preserve financial flexibility in light of the uncertainty resulting from the COVID-19 pandemic, the Company borrowed an additional $17.4 million on its revolving credit facility with Macquarie Capital ("Macquarie") and its credit agreement with UniCredit Bank Austria AG ("UniCredit"). The Company has no remaining availability under these credit facilities. As of April 30, 2020, the Company had $50.0 million in cash on hand. The Company currently is not generating any revenue from its properties, and estimates that the net cash outflow during the time the operations continue to be fully suspended will be, on average, approximately $8.0 million per month. Management estimates that the Company will need approximately $19.8 million to reopen operations and cover short-term cash needs at the casinos. During the first quarter of 2020, the Company concluded that the COVID-19 pandemic and associated closure of its casinos were triggering events that could indicate possible impairment of its goodwill and indefinite-lived intangible assets. The Company performed a quantitative and qualitative impairment analysis and determined that goodwill and casino licenses related to certain reporting units were impaired. As a result, the Company recorded $33.0 million to impairment - goodwill and intangible assets on its condensed consolidated statement of (loss) earnings for the three months ended March 31, 2020."

  • 20

    May

  • 05

    Jun

CNTY Century Casinos
$4.10 /

+0.16 (+4.06%)

02/25/20 Roth Capital
Roth sees upside in Century Casinos shares after co-CEO meetings
10/21/19 Union Gaming
Century Casinos upgraded to Buy from Hold at Union Gaming
06/17/19 Craig-Hallum
Century Casinos acquisition to increase U.S. exposure, says Craig-Hallum

TODAY'S FREE FLY STORIES

Recommendations
EverQuote price target raised to $65 from $50 at Oppenheimer » 07:30
06/02/20
06/02
07:30
06/02/20
07:30
EVER

EverQuote

$56.89 /

+3.4 (+6.36%)

Oppenheimer analyst Jed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVER EverQuote
$56.89 /

+3.4 (+6.36%)

EVER EverQuote
$56.89 /

+3.4 (+6.36%)

05/27/20 Canaccord
EverQuote price target raised to $60 from $50 at Canaccord
05/05/20 Needham
EverQuote price target raised to $55 from $45 at Needham
05/05/20 Canaccord
EverQuote price target raised to $50 from $48 at Canaccord
02/27/20 JMP Securities
EverQuote price target raised to $50 from $35 at JMP Securities
EVER EverQuote
$56.89 /

+3.4 (+6.36%)

EVER EverQuote
$56.89 /

+3.4 (+6.36%)

EVER EverQuote
$56.89 /

+3.4 (+6.36%)

EVER EverQuote
$56.89 /

+3.4 (+6.36%)

Recommendations
Rightmove price target lowered to 540 GBp from 640 GBp at Deutsche Bank » 07:29
06/02/20
06/02
07:29
06/02/20
07:29
RTMVY

Rightmove

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RTMVY Rightmove
$0.00 /

+ (+0.00%)

05/18/20 UBS
Rightmove price target lowered to 500 GBp from 510 GBp at UBS
04/29/20 Barclays
Rightmove price target lowered to 400 GBp from 405 GBp at Barclays
04/15/20 RBC Capital
Rightmove downgraded to Underperform from Sector Perform at RBC Capital
03/26/20 Morgan Stanley
Rightmove price target lowered to 550 GBp from 560 GBp at Morgan Stanley
Initiation
Exagen assumed with an Overweight at Cantor Fitzgerald » 07:29
06/02/20
06/02
07:29
06/02/20
07:29
XGN

Exagen

$11.20 /

-0.39 (-3.36%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XGN Exagen
$11.20 /

-0.39 (-3.36%)

XGN Exagen
$11.20 /

-0.39 (-3.36%)

06/01/20 Cantor Fitzgerald
Exagen assumed with an Overweight at Cantor Fitzgerald
03/26/20 Cantor Fitzgerald
Exagen price target lowered to $19 from $25 at Cantor Fitzgerald
03/02/20 Cantor Fitzgerald
Exagen should beat Q4 revenue estimates, says Cantor Fitzgerald
10/14/19 Cantor Fitzgerald
Exagen initiated with an Overweight at Cantor Fitzgerald
XGN Exagen
$11.20 /

-0.39 (-3.36%)

Recommendations
Visa price target raised to $220 from $200 at SunTrust » 07:29
06/02/20
06/02
07:29
06/02/20
07:29
V

Visa

$194.45 /

-0.68 (-0.35%)

SunTrust analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
V Visa
$194.45 /

-0.68 (-0.35%)

V Visa
$194.45 /

-0.68 (-0.35%)

06/01/20 Wedbush
Visa price target raised to $220 from $200 at Wedbush
05/20/20 Cowen
Visa price target raised to $196 from $189 at Cowen
05/06/20 Stephens
Visa franchises will exit recession stronger, says Stephens
05/04/20 BMO Capital
Visa price target lowered to $213 from $234 at BMO Capital
V Visa
$194.45 /

-0.68 (-0.35%)

V Visa
$194.45 /

-0.68 (-0.35%)

V Visa
$194.45 /

-0.68 (-0.35%)

V Visa
$194.45 /

-0.68 (-0.35%)

Recommendations
Adevinta price target raised to NOK 110 from NOK 100 at Deutsche Bank » 07:28
06/02/20
06/02
07:28
06/02/20
07:28
ADEVF

Adevinta

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADEVF Adevinta
$0.00 /

+ (+0.00%)

04/22/20 JPMorgan
Adevinta price target raised to NOK 101 from NOK 97 at JPMorgan
04/03/20 Kepler Cheuvreux
Adevinta upgraded to Hold from Reduce at Kepler Cheuvreux
Upgrade
Auto Trader Group upgraded to Buy from Hold at Deutsche Bank » 07:28
06/02/20
06/02
07:28
06/02/20
07:28
ATDRY

Auto Trader Group

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATDRY Auto Trader Group
$0.00 /

+ (+0.00%)

05/12/20 UBS
UBS maintains Buy on Auto Trader, says forecasts ahead of consensus
05/04/20 JPMorgan
Auto Trader Group price target lowered to 348 GBp from 368 GBp at JPMorgan
04/29/20 Barclays
Auto Trader Group price target raised to 440 GBp from 420 GBp at Barclays
04/16/20 UBS
Auto Trader Group upgraded to Buy from Neutral at UBS
Downgrade
Evolent Health downgraded to Neutral from Overweight at Cantor Fitzgerald » 07:27
06/02/20
06/02
07:27
06/02/20
07:27
EVH

Evolent Health

$6.84 /

-2.05 (-23.06%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

06/01/20 Cantor Fitzgerald
Evolent Health downgraded to Neutral from Overweight at Cantor Fitzgerald
06/01/20 Piper Sandler
Evolent Health core business is undervalued, says Piper Sandler
06/01/20 Cantor Fitzgerald
Evolent Health price target lowered to $9 from $14 at Cantor Fitzgerald
06/01/20 Piper Sandler
Kentucky contract positive for Molina, negative for Anthem, says Piper Sandler
EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

Syndicate
RenaissanceRe announces public offering of 5.5M common shares » 07:27
06/02/20
06/02
07:27
06/02/20
07:27
RNR

RenaissanceRe

$164.90 /

-3.05 (-1.82%)

RenaissanceRe Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RNR RenaissanceRe
$164.90 /

-3.05 (-1.82%)

RNR RenaissanceRe
$164.90 /

-3.05 (-1.82%)

01/21/20 Citi
RenaissanceRe initiated with a Neutral at Citi
12/16/19 Wells Fargo
Wells Fargo upgrades RenaissanceRe to Overweight with $220 price target
12/16/19 Wells Fargo
RenaissanceRe upgraded to Overweight from Equal Weight at Wells Fargo
11/12/19 JPMorgan
RenaissanceRe assumed with an Underweight from Neutral at JPMorgan
RNR RenaissanceRe
$164.90 /

-3.05 (-1.82%)

Initiation
Middleby resumed with a Buy at CL King » 07:27
06/02/20
06/02
07:27
06/02/20
07:27
MIDD

Middleby

/

+

CL King analyst Todd…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MIDD Middleby
/

+

MIDD Middleby
/

+

01/17/20 Buckingham
Middleby equimpment may be used for new McDonald's sandwich, says Buckingham
11/07/19 Wellington Shields
Middleby downgraded to Hold from Gradually Accumulate at Great Lakes Review
08/07/19 Buckingham
Buckingham says Middleby visibility has deteriorated, cuts target to $153
07/10/19 Citi
Welbilt upgraded to Buy from Neutral at Citi
MIDD Middleby
/

+

MIDD Middleby
/

+

Upgrade
Citi upgraded to Buy from Hold at Odeon Capital » 07:27
06/02/20
06/02
07:27
06/02/20
07:27
C

Citi

$49.46 /

+1.57 (+3.28%)

Odeon Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
C Citi
$49.46 /

+1.57 (+3.28%)

C Citi
$49.46 /

+1.57 (+3.28%)

05/18/20 Standpoint Research
Citi upgraded to Buy from Hold at Standpoint Research
05/14/20 BMO Capital
BMO downgrades PayPal on shift towards credit-sensitive financials
04/20/20 Argus
Citi upgraded to Buy at Argus on valuation
04/20/20 Argus
Citi upgraded to Buy from Hold at Argus
C Citi
$49.46 /

+1.57 (+3.28%)

C Citi
$49.46 /

+1.57 (+3.28%)

C Citi
$49.46 /

+1.57 (+3.28%)

C Citi
$49.46 /

+1.57 (+3.28%)

C Citi
$49.46 /

+1.57 (+3.28%)

Recommendations
PayPal price target raised to $183 from $147 at Deutsche Bank » 07:26
06/02/20
06/02
07:26
06/02/20
07:26
PYPL

PayPal

$154.51 /

-0.56 (-0.36%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PYPL PayPal
$154.51 /

-0.56 (-0.36%)

PYPL PayPal
$154.51 /

-0.56 (-0.36%)

06:21 Today BTIG
Western Union-Money Gram review could note more online competition, says BTIG
06/01/20 Wedbush
PayPal price target raised to $176 from $160 at Wedbush
05/28/20 RBC Capital
PayPal price target raised to $159 from $142 at RBC Capital
05/21/20 Bernstein
PayPal e-commerce growth, new users offset competition, says Bernstein
PYPL PayPal
$154.51 /

-0.56 (-0.36%)

PYPL PayPal
$154.51 /

-0.56 (-0.36%)

PYPL PayPal
$154.51 /

-0.56 (-0.36%)

PYPL PayPal
$154.51 /

-0.56 (-0.36%)

Recommendations
Regeneron price target raised to $624 from $400 at Cantor Fitzgerald » 07:25
06/02/20
06/02
07:25
06/02/20
07:25
REGN

Regeneron

$598.88 /

-11.85 (-1.94%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$598.88 /

-11.85 (-1.94%)

REGN Regeneron
$598.88 /

-11.85 (-1.94%)

05/28/20 Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/28/20 Barclays
Regeneron price target raised to $615 from $530 at Barclays
05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20
Fly Intel: Top five analyst upgrades
REGN Regeneron
$598.88 /

-11.85 (-1.94%)

REGN Regeneron
$598.88 /

-11.85 (-1.94%)

REGN Regeneron
$598.88 /

-11.85 (-1.94%)

REGN Regeneron
$598.88 /

-11.85 (-1.94%)

Hot Stocks
Aduro Biotech trading halted, news pending  07:25
06/02/20
06/02
07:25
06/02/20
07:25
ADRO

Aduro Biotech

$3.38 /

+0.1 (+3.05%)

 
ShowHide Related Items >><<
ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

01/10/20 Cowen
Aduro downgraded to Market Perform on limited visibility at Cowen
01/10/20 Cowen
Aduro Biotech downgraded to Market Perform from Outperform at Cowen
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/18/19 William Blair
Aduro Biotech downgraded to Market Perform from Outperform at William Blair
ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

Recommendations
IAC price target raised to $327 from $290 at Deutsche Bank » 07:23
06/02/20
06/02
07:23
06/02/20
07:23
IAC

IAC

$278.70 /

+7.4 (+2.73%)

, MTCH

Match Group

$91.83 /

+3.11 (+3.51%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IAC IAC
$278.70 /

+7.4 (+2.73%)

MTCH Match Group
$91.83 /

+3.11 (+3.51%)

IAC IAC
$278.70 /

+7.4 (+2.73%)

05/11/20 Oppenheimer
IAC price target raised to $275 from $265 at Oppenheimer
05/11/20 Wedbush
IAC price target raised to $290 from $259 at Wedbush
05/08/20 UBS
IAC price target raised to $302 from $282 at UBS
05/08/20 Nomura Instinet
IAC price target raised to $323 from $296 at Nomura Instinet
MTCH Match Group
$91.83 /

+3.11 (+3.51%)

05/11/20 Oppenheimer
IAC price target raised to $275 from $265 at Oppenheimer
05/11/20 Wedbush
IAC price target raised to $290 from $259 at Wedbush
05/08/20 Barclays
IAC price target raised to $290 from $270 at Barclays
05/07/20 Oppenheimer
Match Group price target raised to $95 from $80 at Oppenheimer
IAC IAC
$278.70 /

+7.4 (+2.73%)

MTCH Match Group
$91.83 /

+3.11 (+3.51%)

IAC IAC
$278.70 /

+7.4 (+2.73%)

MTCH Match Group
$91.83 /

+3.11 (+3.51%)

IAC IAC
$278.70 /

+7.4 (+2.73%)

MTCH Match Group
$91.83 /

+3.11 (+3.51%)

IAC IAC
$278.70 /

+7.4 (+2.73%)

MTCH Match Group
$91.83 /

+3.11 (+3.51%)

Upgrade
AbbVie upgraded to Buy from Hold at Argus » 07:23
06/02/20
06/02
07:23
06/02/20
07:23
ABBV

AbbVie

$90.71 /

-2.07 (-2.23%)

Argus analyst David Toung…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$90.71 /

-2.07 (-2.23%)

ABBV AbbVie
$90.71 /

-2.07 (-2.23%)

05/22/20 Piper Sandler
Growth of Biohaven's Nurtec continues to beat AbbVie's Ubrelvy, says Piper
05/21/20 Piper Sandler
Piper Sandler remains Overweight on Synlogic after AbbVie ends collaboration
05/18/20 BofA
AbbVie reinstated with a Neutral at BofA
05/12/20 JPMorgan
AbbVie resumed with an Overweight from Neutral at JPMorgan
ABBV AbbVie
$90.71 /

-2.07 (-2.23%)

ABBV AbbVie
$90.71 /

-2.07 (-2.23%)

ABBV AbbVie
$90.71 /

-2.07 (-2.23%)

ABBV AbbVie
$90.71 /

-2.07 (-2.23%)

Recommendations
Schrodinger price target raised to $85 from $67 at BMO Capital » 07:23
06/02/20
06/02
07:23
06/02/20
07:23
SDGR

Schrodinger

$69.73 /

+1.21 (+1.77%)

BMO Capital analyst Do…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SDGR Schrodinger
$69.73 /

+1.21 (+1.77%)

SDGR Schrodinger
$69.73 /

+1.21 (+1.77%)

03/02/20
Fly Intel: Top five analyst initiations
03/02/20 Jefferies
Schrodinger initiated with a Hold at Jefferies
03/02/20 Morgan Stanley
Schrodinger initiated with an Equal Weight at Morgan Stanley
03/02/20 BMO Capital
Schrodinger initiated with an Outperform at BMO Capital
SDGR Schrodinger
$69.73 /

+1.21 (+1.77%)

SDGR Schrodinger
$69.73 /

+1.21 (+1.77%)

SDGR Schrodinger
$69.73 /

+1.21 (+1.77%)

SDGR Schrodinger
$69.73 /

+1.21 (+1.77%)

Recommendations
Angi Homeservices price target raised to $12.50 from $10 at Deutsche Bank » 07:22
06/02/20
06/02
07:22
06/02/20
07:22
ANGI

Angi Homeservices

$11.15 /

+0.3 (+2.76%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANGI Angi Homeservices
$11.15 /

+0.3 (+2.76%)

ANGI Angi Homeservices
$11.15 /

+0.3 (+2.76%)

05/11/20 Oppenheimer
IAC price target raised to $275 from $265 at Oppenheimer
05/11/20 Citi
Angi Homeservices price target raised to $10 from $6.50 at Citi
05/08/20 Barclays
IAC price target raised to $290 from $270 at Barclays
04/23/20 Wells Fargo
IAC price target lowered to $300 from $310 at Wells Fargo
ANGI Angi Homeservices
$11.15 /

+0.3 (+2.76%)

ANGI Angi Homeservices
$11.15 /

+0.3 (+2.76%)

ANGI Angi Homeservices
$11.15 /

+0.3 (+2.76%)

Upgrade
Quest Diagnostics resumed to Buy from Hold at Deutsche Bank » 07:20
06/02/20
06/02
07:20
06/02/20
07:20
DGX

Quest Diagnostics

$118.32 /

-0.01 (-0.01%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DGX Quest Diagnostics
$118.32 /

-0.01 (-0.01%)

DGX Quest Diagnostics
$118.32 /

-0.01 (-0.01%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
04/28/20
Fly Intel: Top five analyst upgrades
04/28/20 Morgan Stanley
Morgan Stanley upgrades Quest Diagnostics to Overweight on COVID testing boost
04/28/20 Morgan Stanley
Quest Diagnostics upgraded to Overweight from Equal Weight at Morgan Stanley
DGX Quest Diagnostics
$118.32 /

-0.01 (-0.01%)

DGX Quest Diagnostics
$118.32 /

-0.01 (-0.01%)

DGX Quest Diagnostics
$118.32 /

-0.01 (-0.01%)

Initiation
LabCorp resumed with a Buy at Deutsche Bank » 07:18
06/02/20
06/02
07:18
06/02/20
07:18
LH

LabCorp

$176.98 /

+1.175 (+0.67%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LH LabCorp
$176.98 /

+1.175 (+0.67%)

LH LabCorp
$176.98 /

+1.175 (+0.67%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/15/20
Fly Intel: Top five analyst upgrades
05/15/20 Mizuho
LabCorp upgraded to Buy from Neutral at Mizuho
05/13/20 JPMorgan
Adaptive reported 'healthy' Q1 results, says JPMorgan
LH LabCorp
$176.98 /

+1.175 (+0.67%)

LH LabCorp
$176.98 /

+1.175 (+0.67%)

LH LabCorp
$176.98 /

+1.175 (+0.67%)

Hot Stocks
BioCryst reports inducement grants under Nasdaq listing rule » 07:16
06/02/20
06/02
07:16
06/02/20
07:16
BCRX

BioCryst

$4.70 /

+0.2 (+4.45%)

BioCryst Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCRX BioCryst
$4.70 /

+0.2 (+4.45%)

BCRX BioCryst
$4.70 /

+0.2 (+4.45%)

05/06/20 JMP Securities
BioCryst has potential best-in-class PNH treatment, says JMP Securities
05/06/20 Piper Sandler
BioCryst price target raised to $10 from $8 at Piper Sandler
05/05/20 Barclays
BioCryst upgraded to Overweight from Equal Weight at Barclays
04/29/20 JMP Securities
Positive remdesivir news 'bodes well' for BioCryst, says JMP Securities
BCRX BioCryst
$4.70 /

+0.2 (+4.45%)

BCRX BioCryst
$4.70 /

+0.2 (+4.45%)

BCRX BioCryst
$4.70 /

+0.2 (+4.45%)

Hot Stocks
Lexington Realty says approx. 98.9% of May Cash Base Rents paid as of June 1 » 07:16
06/02/20
06/02
07:16
06/02/20
07:16
LXP

Lexington Realty

$9.65 /

-0.07 (-0.72%)

Lexington Realty provided…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LXP Lexington Realty
$9.65 /

-0.07 (-0.72%)

LXP Lexington Realty
$9.65 /

-0.07 (-0.72%)

01/08/20 Stifel
Lexington Realty downgraded to Hold from Buy at Stifel
08/26/19 Wells Fargo
Lexington Realty downgraded to Market Perform from Outperform at Wells Fargo
08/07/19 Stifel
Lexington Realty upgraded to Buy from Hold at Stifel
LXP Lexington Realty
$9.65 /

-0.07 (-0.72%)

Recommendations
NextGen Healthcare price target lowered to $9 from $12 at Deutsche Bank » 07:15
06/02/20
06/02
07:15
06/02/20
07:15
NXGN

NextGen Healthcare

$10.28 /

-0.04 (-0.39%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXGN NextGen Healthcare
$10.28 /

-0.04 (-0.39%)

NXGN NextGen Healthcare
$10.28 /

-0.04 (-0.39%)

05/05/20 Piper Sandler
NextGen Healthcare price target lowered to $17 from $21 at Piper Sandler
04/20/20 RBC Capital
NextGen Healthcare initiated with a Sector Perform at RBC Capital
04/13/20 SVB Leerink
NextGen Healthcare initiated with a Market Perform at SVB Leerink
03/27/20 Wells Fargo
NextGen Healthcare upgraded to Equal Weight from Underweight at Wells Fargo
NXGN NextGen Healthcare
$10.28 /

-0.04 (-0.39%)

Hot Stocks
Esports Entertainment appoints Magnus Leppaniemi as head of esports at Vie.gg » 07:15
06/02/20
06/02
07:15
06/02/20
07:15
GMBL

Esports Entertainment Group

$7.84 /

-0.98 (-11.11%)

Esports Entertainment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMBL Esports Entertainment Group
$7.84 /

-0.98 (-11.11%)

Recommendations
Casey's General Stores price target raised to $175 from $170 at Deutsche Bank » 07:14
06/02/20
06/02
07:14
06/02/20
07:14
CASY

Casey's General Stores

$161.40 /

+1.2 (+0.75%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CASY Casey's General Stores
$161.40 /

+1.2 (+0.75%)

CASY Casey's General Stores
$161.40 /

+1.2 (+0.75%)

04/01/20 Stephens
Casey's General Stores downgraded to Equal Weight from Overweight at Stephens
03/26/20 RBC Capital
Casey's General Stores upgraded to Sector Perform on valuation at RBC Capital
03/25/20 RBC Capital
Casey's General Stores upgraded to Sector Perform from Underperform at RBC Capital
03/24/20 Sidoti
Casey's General Stores upgraded to Buy from Neutral at Sidoti
CASY Casey's General Stores
$161.40 /

+1.2 (+0.75%)

CASY Casey's General Stores
$161.40 /

+1.2 (+0.75%)

Recommendations
Camping World price target raised to $29 from $21 at Stephens » 07:12
06/02/20
06/02
07:12
06/02/20
07:12
CWH

Camping World

$23.13 /

+1.94 (+9.16%)

Stephens analyst Rick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CWH Camping World
$23.13 /

+1.94 (+9.16%)

CWH Camping World
$23.13 /

+1.94 (+9.16%)

06/01/20 Monness Crespi
Camping World price target raised to $24 from $18 at Monness Crespi
05/12/20 BMO Capital
Camping World price target raised to $13 from $8.50 at BMO Capital
04/27/20 BMO Capital
Camping World price target lowered to $8.50 from $12 at BMO Capital
04/08/20 Northcoast
Thor Industries, Camping World downgraded at Northcoast after RV industry checks
CWH Camping World
$23.13 /

+1.94 (+9.16%)

CWH Camping World
$23.13 /

+1.94 (+9.16%)

CWH Camping World
$23.13 /

+1.94 (+9.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.